Lilly Targets Dr. Reddy's Over Gemzar ANDA
Eli Lilly & Co. has accused generic-drug maker Dr. Reddy's Laboratories Ltd. of infringing a method patent for Gemzar in its attempt to launch a copycat version of the cancer treatment,...To view the full article, register now.
Already a subscriber? Click here to view full article